A Preview of MDUFA VI: Changes and Highlights, Part 1

MDUFA VI, the upcoming iteration of the Medical Device User Fee Act, aims to refine the regulatory landscape for medical devices by introducing new fee structures and procedural changes. A central development involves a proposed $2,000 fee for pre-submissions, intended to reduce misuse of the process by unprepared applicants. While the introduction of a "Focused Follow-up Pre-submission" program seeks to streamline interactions, concerns persist regarding administrative complexity and the potential for "predicate creep." Furthermore, the significant disparity between 510(k) and de novo user fees—with the latter being ten times higher—creates a financial barrier that may inadvertently discourage novel innovation. Ensuring FDA accountability and consistent review standards remains critical, as current administrative pressures sometimes lead to premature closure of submissions to meet reporting metrics, undermining the intended collaborative nature of the regulatory process.